Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Kosan Biosciences, Inc. (NasdaqNM:KOSN)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials | Reports
Location
3832 Bay Center Place
Hayward, CA 94545
Phone: (510) 732-8400
Fax: (510) 732-8401
Employees (last reported count): 81
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Employment
 ·Products & Services
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 52%
·Over the last 6 months:
 · one insider buy; 1.29M shares (11.0% of insider shares)
·Institutional: 11% (23% of float)
(37 institutions)
·Net Inst. Buying: 1.78M shares (+38.95%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Kosan Biosciences, Inc. is a biotechnology company that uses its proprietary technologies to develop drug candidates from a class of natural product compounds known as polyketides. Polyketides are found in very small amounts in microorganisms and are difficult to make or modify chemically. The Company's proprietary technologies are designed to create, modify and produce polyketides in ways that chemists cannot. The Company's technology platform has five components: polyketide gene alteration, chemo-biosynthesis, heterologous over-expression, combinatorial biosynthesis and screening libraries. Together, its technologies enable Kosan to modify, create and produce proprietary polyketides with potential for development as valuable pharmaceutical products.
More from Market Guide: Expanded Business Description

Financial Summary
KOSN is a biotechnology company using proprietary technologies to develop drug candidates from an important class of natural product compounds known as polyketides. For the six months ended 6/30/01, revenues fell 1% to $2.2 million. Net loss applicable to Common fell 39% to $10.9 million. Revenues reflect a decrease in contract sales attributable to the absence of an up-front fee received in 2000. Lower loss reflects the absence of $11.3 million in preferred dividends.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Daniel Santi, M.D., Ph.D., 59
Chairman, CEO
$318K--  
Susan Kanaya, 38
CFO, VP-Fin.
203K$45K
Michael Ostrach, 49
Sr. VP, COO
264K36K
Brian Metcalf, Ph.D., 55
Sr. VP, CSO
409K--  
Robert Johnson, Jr., M.D., Ph.D., 49
VP, Medical Affairs and Corp. Devel.
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:KOSNAs of 31-Aug-2001
Price and Volume
52-Week Low
on 29-Mar-2001
$6.625
Recent Price$7.91 
52-Week High
on 25-Oct-2000
$19.25 
Daily Volume (3-month avg)60.2K
Daily Volume (10-day avg)92.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y]
26-Week Change-15.6%
26-Week Change
relative to S&P500
-8.1%
Share-Related Items
Market Capitalization$199.3M
Shares Outstanding25.2M
Float12.1M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$3.78 
Earnings (ttm)-$1.44 
Earnings (mrq)-$0.29 
Sales (ttm)$0.23 
Cash (mrq)$3.23 
Valuation Ratios
Price/Book (mrq)2.09 
Price/EarningsN/A 
Price/Sales (ttm)35.11 
Income Statements
Sales (ttm)$4.21M
EBITDA (ttm)-$14.6M
Income available to common (ttm)-$19.3M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-25.03%
Return on Equity (ttm)-26.98%
Financial Strength
Current Ratio (mrq)21.09 
Debt/Equity (mrq)0.03 
Total Cash (mrq)$81.3M
Short Interest
As of 8-Aug-2001
Shares Short38.0K
Percent of Float0.3%
Shares Short
(Prior Month)
72.0K
Short Ratio1.41 
Daily Volume27.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.